Apothecary Pharma, LLC
FDA 503B outsourcing facility
Cary, North Carolina
Key Takeaways
- FDA-registered 503B outsourcing facility since 2024
- Sterile compounding from bulk substances: Yes
- Last FDA inspection: May 15, 2025
- FDA action: Warning Letter Issued 12/1/2025
About this facility
A 503B outsourcing facility is registered with the FDA under the Drug Quality and Security Act and may compound sterile medications in bulk without patient-specific prescriptions, under cGMP manufacturing standards. How federal compounding status works.
FDA registration and inspection record
- First registered with FDA
- September 7, 2024
- Most recent registration
- January 6, 2026
- Compounds sterile drugs from bulk substances
- Yes
- Last FDA inspection
- May 15, 2025
The FDA last inspected Apothecary Pharma, LLC on May 15, 2025. Investigators issued a Form FDA 483 listing inspectional observations at that visit. FDA action on record: Warning Letter Issued 12/1/2025.
Compounded peptides and GLP-1s
Apothecary Pharma, LLC has not assigned NDCs or filed product reports in the most recent FDA reporting periods. 503B outsourcing facilities are a primary supply route for compounded peptides and GLP-1s during FDA-listed shortages; PeptideGrids grades the evidence for each, including Semaglutide, Tirzepatide, BPC-157, Retatrutide. Browse the GLP-1 and therapeutic peptide databases.
Location
1913 Evans Rd, Cary, NC 27513
Satellite and street imagery via Esri. Open larger map.
Contact
FDA-registered contact: Priyanka Rana, 1-919-760-5478. Source: the facility's FDA outsourcing registration.
License verification
503B outsourcing facilities are also licensed by the state board of pharmacy. Verify the current license status of Apothecary Pharma, LLC with the North Carolina Board of Pharmacy.
503B facilities in North Carolina
Frequently asked questions
Is Apothecary Pharma, LLC registered with the FDA?
Yes. Apothecary Pharma, LLC is a registered 503B outsourcing facility, first registered with the FDA on September 7, 2024 and most recently registered on January 6, 2026.
Has Apothecary Pharma, LLC been inspected by the FDA?
The FDA last inspected Apothecary Pharma, LLC on May 15, 2025. A Form FDA 483 was issued. FDA action on record: Warning Letter Issued 12/1/2025.
Has Apothecary Pharma, LLC had any FDA drug recalls?
No FDA drug recalls are matched to Apothecary Pharma, LLC in the openFDA enforcement database.
What does Apothecary Pharma, LLC compound?
Apothecary Pharma, LLC has not filed product reports with NDC-assigned drugs in the most recent FDA reporting periods.
Where is Apothecary Pharma, LLC located?
Apothecary Pharma, LLC is located in Cary, North Carolina (1913 Evans Rd).
Registration and inspection data verified against the FDA list of registered outsourcing facilities on June 6, 2026.
PeptideGrids is independent and not affiliated with, endorsed by, or sponsored by Apothecary Pharma, LLC. Listings, registration, inspection, and recall data are reported from public FDA records for informational purposes only. A recall or inspection finding is not an accusation of current wrongdoing. This is not medical or legal advice. To request a correction, see our corrections policy.